We have plenty of cash to get a second indication ready for the clinic ...... If it is TBI and or Stroke why, would we not have that packaged up and ready to go. Once again our drug lowers ICP. It just happens that ICP, is the major symptom of IIH specifically. So if we can prove we can lower ICP in a Phase III trial, we are able to lower ICP in all patients not just IIH patients. If that is the case I am certain that we will find plenty of interest for a clinic ready package in TBI or Stroke.
https://youtu.be/dJ52IowmB4k?t=1262
IXC Charting Thread, page-302
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
